On the recordMarch 19, 2013
Therefore, this hearing is an appropriate place to examine the extent to which the FDA and other federal agencies should be involved in regulation of health information technologies.
Source
congress.govTherefore, this hearing is an appropriate place to examine the extent to which the FDA and other federal agencies should be involved in regulation of health information technologies.
Pitts emphasizes the need for regulatory examination of health information technologies.
Share
More from Joe Pitts
So, moving forward, the committee welcomes feedback on how we can improve care for children with medical complexity without disrupting the successful approaches already in place.
We will hear from witnesses on ways to address our trauma and emergency medical systems.
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
Today's hearing is an important discussion that will examine the areas where we can improve our national trauma system.